Published in Z Rheumatol on February 01, 2011
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum (2002) 3.55
Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 2.69
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med (2004) 2.43
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) (2009) 1.99
Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum (2007) 1.96
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) (2007) 1.95
Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med (2009) 1.74
Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 1.66
Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study. Br J Dermatol (2009) 1.59
Methotrexate in systemic lupus erythematosus. Lupus (2005) 1.57
Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol (2005) 1.54
Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol (1996) 1.51
Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol (2009) 1.48
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis (2007) 1.37
Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev (2006) 1.34
Treatment of corticosteroid-resistant polymyositis with methotrexate. Lancet (1971) 1.27
Maintenance of remission with leflunomide in Wegener's granulomatosis. Rheumatology (Oxford) (2004) 1.08
Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial. J Rheumatol (2004) 1.06
Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol (2005) 1.03
Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr (2007) 0.99
Methotrexate in primary Sjögren's syndrome. Clin Exp Rheumatol (1997) 0.98
Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol (2000) 0.96
Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease. J Neurol Sci (1998) 0.95
Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. J Rheumatol (1999) 0.90
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum (2008) 0.90
Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients. Rheumatology (Oxford) (2010) 0.88
Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol (2008) 0.87
Evaluation of oral methotrexate in the treatment of systemic sclerosis. Int J Dermatol (2007) 0.85
Churg Strauss syndrome--successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment. Clin Exp Rheumatol (2004) 0.85
Sjögren's syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs (2000) 0.84
Methotrexate therapy in systemic lupus erythematosus. Lupus (2001) 0.81
Methotrexate plus leflunomide for the treatment of relapsingWegener's granulomatosis. A retrospective uncontrolled study. Clin Exp Rheumatol (2010) 0.78
Leflunomide versus methotrexate in Wegener's granulomatosis. Rheumatology (Oxford) (2007) 0.77
Innovative management of lupus erythematosus. Dermatol Clin (2010) 0.77
Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol (1995) 0.76
Methotrexate treatment in dermatomyositis. Eur Neurol (1977) 0.75
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]. Z Rheumatol (2012) 1.91
[Amendment of the structural quality for inpatient rheumatology. A forward-looking concept]. Z Rheumatol (2011) 1.74
Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ (2007) 1.50
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]. Z Rheumatol (2011) 1.21
Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist? Ann Rheum Dis (2005) 0.94
Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis. Ann Rheum Dis (2004) 0.92
The role of DMARDs in systemic sclerosis therapy. Rheumatology (Oxford) (2006) 0.86
Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosus. Scand J Rheumatol (2006) 0.85
Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: a report on one treatment for the combined manifestation of two diseases. Rheumatology (Oxford) (2005) 0.82
Safety of 15-deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus. Ann Rheum Dis (2005) 0.81
[Fever and arthritis: rheumatic or Whipple's disease?]. Dtsch Med Wochenschr (2011) 0.79
Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk. Scand J Rheumatol (2012) 0.78
[Problems associated with treating ocular disease in underlying inflammatory rheumatic disease]. Z Rheumatol (2010) 0.76
[Mesenchymal stroma cells (MSCs) for the treatment of rheumatic disease]. Dtsch Med Wochenschr (2013) 0.75
[Regulatory B cells and their role in maintaining peripheral tolerance]. Z Rheumatol (2010) 0.75
[60-year-old patient with refractory polyarthritis]. Dtsch Med Wochenschr (2013) 0.75
[Radiographic healing of sarcoid bone erosion]. Z Rheumatol (2009) 0.75
[Personalized medicine in the choice of conventional immunosuppressants and disease modifying antirheumatic drugs]. Z Rheumatol (2013) 0.75
[New aspects of the pathogenesis of systemic lupus erythematosus]. Z Rheumatol (2007) 0.75